Trials / Active Not Recruiting
Active Not RecruitingNCT07354529
Date Fruit Benefits to Treat Morning Sickness in First Trimester of Pregnancy
Evaluation of Benefits of Date Fruit in the First Trimester of Pregnancy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Bahria University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating morning sickness of pregnancy in pregnant females. The main question\[s\] it aims to answer \[is/are\]: The goal of this randomized clinical trial is to evaluate role of date fruit in The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating vomiting due to morning sickness of pregnancy and in improving maternal hemoglobin in pregnant females. The main question\[s\] it aims to answer \[are\]: * Role of date fruit in alleviating severity and frequency of vomiting due to morning sickness of pregnancy in pregnant females. * Role of date fruit in improving haemoglobin levels in pregnant females. * To assess improvement of severity and frequency of vomiting due to morning sickness of pregnancy and improvement of hemoglobin levels in pregnant females, researchers will compare date fruit intake with antiemetic medication doxylamine succinate 10 mg + pyridoxine HCl 10 and diet only.
Detailed description
A randomized Controlled trial to assess benefits of date fruit in morning sickness of pregnancy symptoms, inclusive of nausea and vomiting and to improve haemoglobin levels in pregnant females.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Date fruit | 3 Dates after breakfast |
| DRUG | Doxylamine succinate 10 mg + Pyridoxine HCl 10 mg | Doxylamine succinate 10 mg + Pyridoxine HCl 10 mg , One per day |
| OTHER | Diet | Avoidance of high in fat foods and enhanced intake of hydrating fruits and vegetables |
Timeline
- Start date
- 2025-06-15
- Primary completion
- 2026-01-25
- Completion
- 2026-02-01
- First posted
- 2026-01-21
- Last updated
- 2026-01-21
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07354529. Inclusion in this directory is not an endorsement.